PepGen Inc.
PEPG
Rank in Stocks
#17515
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide... PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
Share Price
$2.39
Last synced: 2026-11-09
Market Cap
$165.31M
Change (1 day)
-3.24%
Change (1 year)
-48.60%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade PepGen Inc. (PEPG)
Category
Healthcare
EPS for PepGen Inc. (PEPG)
EPS as of June 2026 TTM: $-1.50
According to PepGen Inc.'s latest financial reports, its current EPS (TTM) is $-1.50. At the end of 2025 the company had an EPS of $-2.12, an increase over its 2024 EPS of $-2.85.
EPS history for PepGen Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.50 | -29.25% |
| 2025 | $-2.12 | -25.61% |
| 2024 | $-2.85 | -13.64% |
| 2023 | $-3.30 | -25.34% |
| 2022 | $-4.42 | 262.30% |
| 2021 | $-1.22 | 130.19% |
| 2020 | $-0.53 | 781.86% |
| 2019 | $-0.06 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -1,144.00% |
US
|
|
| $-7.07 | 371.33% |
US
|
|
| $-5.29 | 252.67% |
AU
|
|
| $12.88 | -958.67% |
BE
|
|
| $21.56 | -1,537.33% |
NL
|
Questions about PepGen Inc.'s earnings per share (EPS)
What is PepGen Inc.'s earnings per share (EPS)?
PepGen Inc.'s earnings per share (EPS) over the last twelve months is $-1.50, as of Jun 2026.
What was PepGen Inc.'s earnings per share (EPS) in 2025?
In 2025, PepGen Inc.'s earnings per share (EPS) was $-2.12, compared with $-2.85 in 2024.
How has PepGen Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, PepGen Inc.'s earnings per share (EPS) was highest in 2020 ($-0.53) and lowest in 2022 ($-4.42).
How does PepGen Inc.'s earnings per share (EPS) compare with similar companies?
PepGen Inc.'s earnings per share (EPS) ($-1.50) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.